Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Akebia Therapeutics | AKBA - Laba Operasional
Keuangan
Harga Saham
USD
Aktiva
USD 362.52M
Kas Dan Setara
USD 162.64M
Biaya Penjualan
USD 10.34M
Aset Lancar
USD 243.48M
Kewajiban Lancar
USD 173.88M
UTANG
USD 46.51M
Dividen - Hasil
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
Karyawan
167
Eps Laba Per Saham
USD -0.04
Modal Dan Cadangan
USD 27.38M
Laba Kotor Pada Penjualan
USD 47.28M
Beban Bunga Utang
362.52M
Modal Pinjaman
USD 36.4M
Kapitalisasi Pasar
USD 276.4M
Batas Pemasukan
USD -12.24M
Biaya Operasional
USD 63.08M
Laba Operasional
USD -5.45M
Modal Saham Biasa
USD 265.43M
Pe Harga Untuk Laba
1.63K
Laba Sebelum Pajak
USD -11.24M
Pendapatan Penjualan
USD 57.62M
Beban Penjualan Dan Administrasi
USD 23.53M
Saham
USD 13M
Kreditur Perdagangan
USD 8.39M
Debitur Perdagangan
USD 47.03M
Laba Operasional
Perubahan
Tanggal
Acadia Pharmaceuticals
USD -4.62M
22.01M
2026-03
Agios Pharmaceuticals
USD -110.02M
11.55M
2026-03
Akebia Therapeutics
USD -5.45M
9.4M
2025-12
Alnylam Pharmaceuticals
USD 112.6M
24.99M
2026-06
Amgen
USD 3.83B
130M
2026-03
Ardelyx
USD -32.79M
37.89M
2026-03
Astellas Pharma
JPY 48.57B
85.97B
2026-03
AstraZeneca
USD 3.16B
3.95B
2026-06
Bayer
EUR 3.53B
2.42B
2026-03
BioMarin Pharmaceutical
USD 129.65M
68.74M
2026-03
Celltrion
KRW 12.9B
822.77M
2026-03
Cspc Pharmaceutical
CNY 206.26M
1.02B
2025-12
Deva Holding AS
TRY 964.87M
240.32M
2023-09
Dianthus Therapeutics
USD -46.53M
23.01M
2026-03
Exelixis
USD 251.34M
15.43M
2026-03
Fresenius Medical Care
EUR 268M
395M
2026-03
GlaxoSmithKline
GBP 2.6B
312M
2026-06
Ionis Pharmaceuticals
USD -102.29M
15.71M
2026-06
Ironwood Pharmaceuticals
USD 33.22M
7.58M
2024-12
J&J
USD 7.48B
860M
2026-06
Kangmei Pharma
CNY -10.94M
15.75M
2026-03
Karyopharm Therapeutics
USD -17.84M
13.44M
2025-12
Knight Therapeutics
CAD 6.21M
3.27M
2025-12
Laboratorios Farma
EUR 135.05M
49.84M
2023-12
Lexicon Pharmaceuticals
USD -14.78M
2.59M
2025-12
Malin Corporation
EUR -1.1M
400K
2024-12
Medical Developments International
AUD -36K
444K
2025-12
Moderna
USD -815M
573M
2026-06
Nektar Therapeutics
USD -19.09M
15.26M
2025-12
Neuren Pharmaceuticals
AUD 17.01M
11.56M
2025-12
Organigram Holdings
CAD -9.79M
10.33M
2026-03
Ovoca Bio
EUR -1.16M
4.48M
2025-06
Pharma Mar
EUR 622K
42.99M
2026-03
Prothena
USD 25.79M
53M
2026-03
PTC Therapeutics
USD 45.89M
127.51M
2026-03
Qiagen NV
USD 116.63M
5.25M
2026-03
Regeneron Pharmaceuticals
USD 1.42B
675.7M
2026-06
Roche Holding
CHF 11.46B
1.91B
2026-06
Sanofi
EUR 2.38B
449M
2026-06
Sarepta Therapeutics
USD 358.43M
768.52M
2026-03
Sartorius
EUR 164M
3.3M
2026-06
Sino Biopharmaceutical
CNY 5.18B
3.32B
2025-06
Tectonic Therapeutic
USD -27.3M
5.78M
2026-03
Tilray
USD -20.01M
9.34M
2025-09
Vanda Pharmaceuticals
USD -40.66M
29.66M
2024-12
Zealand Pharma A/S
-707.05M
245.73M
2025-12
Zz Pientze Pharmaceu
CNY 837.81M
336.48M
2026-03
×